Eton Pharmaceuticals is a specialty pharmaceutical company that develops and commercializes treatments for rare diseases, with a focused portfolio in endocrinology and metabolic disorders. The company generates revenue by marketing and distributing eight FDA-approved products through its internal sales force and specialty pharmacy channels, while building a pipeline of late-stage candidates through a combination of internal development and strategic acquisitions. Eton's business model leverages its expertise in regulatory pathways, business development sourcing, and commercial infrastructure to identify, acquire, and efficiently launch treatments for small patient populations, with a patient support program and healthcare professional relationships supporting commercialization of its specialty therapies.